Elizabeth Holmes, Theranos and America’s Cannabis Laws Reveal a Stark Divide in Justice, Where Wealthy, Well-Connected White Elites Retain Powerful Allies While Ordinary Americans Face Lasting Consequences.
The powerful men who helped Elizabeth Holmes build Theranos had money, influence and access to America’s business and political elite. Many were older, wealthy, well-connected and white. When her medical technology company collapsed and Holmes was convicted of fraud, some supporters continued to stand by her. The difference between the Elizabeth Holmes and cannabis convictions are striking.
Ordinary Americans—including medical marijuana patients and caregivers—have faced prosecution, prison sentences and criminal records for cannabis offenses. Some believed they were acting legally under state medical marijuana protections. Others were punished for possessing or distributing a substance now legal in some form in most states.
The contrast raises an uncomfortable question: Why do some powerful people retain influential allies after their promises fail, while ordinary Americans can pay for cannabis convictions for years? Â Why do older, white men move mountains to help Holmes but speed millions to ensure Mike Johnson and other politicians punish cannabis users?
RELATED: Cannabis Helps The Young And Old Sleep
Holmes convinced prominent investors, including Oracle founder Larry Ellison, media mogul Rupert Murdoch and members of the Walton family, to back her vision of blood testing using just a few drops of blood. Former secretaries of state George Shultz and Henry Kissinger also lent their names and credibility to Theranos.
But the technology failed to deliver on its promises.
Holmes was convicted of defrauding investors. Patients who relied on Theranos blood tests had their own reasons to feel betrayed. Inaccurate results could trigger unnecessary procedures, create needless fear or lead to medical decisions based on faulty information. For some, the consequences could be even more serious: lost time, delayed care and a missed opportunity for more effective treatment.
In one documented case, a patient received a false-positive HIV result subsequent tests contradicted.
Investors lost money. Patients risked something more personal: their health, peace of mind and potentially their life.
The American Medical Association recognizes the potential medical benefits of cannabis and supports further research and physician guidance. Theranos never received comparable medical endorsement for its blood-testing technology.
Yet Americans using medical marijuana have faced criminal prosecution, while Holmes built her company with backing from older, wealthy, well-connected white men—some of whom continue to support her.
The contrast is striking. Cannabis patients and caregivers have sometimes struggled to navigate conflicting state and federal laws, even when they believed they were acting within legal medical marijuana protections.
Consider the Kettle Falls Five case in Washington state. Five people were prosecuted federally over cannabis grown for medical use, including cancer patient Larry Harvey. In 2015, they were acquitted of four of the five counts against them. Their case became a symbol of the conflict between state medical marijuana protections and federal prohibition.
These were not billionaire investors or Silicon Valley executives. They were ordinary people caught between changing medical attitudes and laws which could still expose them to prosecution.
Holmes’s case and cannabis convictions are not identical. She was convicted of fraud, while marijuana cases vary widely in their circumstances and severity. But the disparity in resources, support and the amount of older white politicians lifting up Holmes and attacking cannabis is difficult to overlook.
Holmes’access to wealthy investors, influential advisers and a network helped make her one of the most celebrated entrepreneurs in America. Venture capitalist Tim Draper, an early investor, has continued to express support for her yet has expressed no faith in cannabis.
People convicted of cannabis offenses often have no comparable safety net. A criminal record can make finding a job, securing housing or obtaining professional licenses harder long after a sentence ends. And Black Americans have historically faced substantially higher marijuana arrest rates than white Americans despite comparable rates of use.
RELATED: The Congressmen Trying To Squash Cannabis
As cannabis becomes legal in more states, those convicted under earlier laws are still left dealing with the consequences. Legalization does not automatically erase a criminal record or restore lost opportunities.
America’s cannabis debate is increasingly about business, tax revenue and a growing legal industry and access to medical treatments.
Holmes’s story is a reminder money and influence can help a person retain powerful defenders after a conviction. It also shows a pretty, white girl can move a mountain or news cycle way more they helping those in chemotherapy experiencing nausea. The experiences of cannabis patients and everyday Americans show what happens when those advantages are missing.
Holmes is an example of the aging establishment reenforcing their desires on the greater population. And when she walks out of prison, she will not care about those left behind.
